Defiance ETFs has launched the Defiance Autism Impact ETF ASD, a first-of-its-kind ETF designed to give investors exposure to companies developing products, therapies, services, and technologies that support individuals with autism and related neurodevelopmental conditions.

The launch marks the culmination of a strategy first outlined in a March regulatory filing and introduces a rare combination of thematic investing and philanthropy. The fund arrives as investors continue to show interest in health care innovation themes ranging from AI-powered drug discovery to next-generation therapeutics and medical technologies.

Defiance CEO Matthew Bielski said the fund was inspired by his personal experience raising a profoundly autistic child. He noted that autism is a broad spectrum encompassing neurological, developmental, behavioral, and biological challenges that affect individuals differently, and expressed hope that the ETF will help channel capital toward companies working to improve quality of life for affected individuals and their families.

Key Features of ASD ETF

• Index Tracked: VettaFi Autism Impact Index
• Strategy: Replication-based index ETF
• Focus: Companies developing products, services, therapies, diagnostics, technologies, and support solutions related to autism and neurodevelopmental conditions
• Expense ratio: 0.79%
• Potential Exposure Areas:
  • Neurodevelopment therapeutics
  • Behavioral and communication support tools
  • Diagnostics and genetic technologies
  • Specialized education platforms
  • Neuroscience and brain health research
  • Sleep and developmental support technologies
  • Digital health and assistive technologies
• Sector Coverage: Health care, pharmaceuticals, biotechnology, diagnostics, education technology, behavioral services, and assistive technologies
• Philanthropic Commitment: Defiance will donate 100% of the ETF's net profits during its first two years to autism-focused nonprofit organizations, and at least 50% of annual net profits thereafter. The donations are made at the adviser level and will not impact the fund's expense ratio or investor returns.

Bottom Line

ASD stands apart from traditional health care ETFs by combining exposure to autism-related innovation with a long-term charitable mission, offering investors a way to participate in advancing therapies, diagnostics, and support services while contributing to autism-focused causes.